DELIVERY ORDER

CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027

Awarded to MCKESSON CORPORATION

PIID 15B11727F00000004US · USAspendingBiotechnology & Pharmaceuticals
$300
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$300sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateOct 1, 2026
Company legal name
MCKESSON CORPORATION
UEI / CAGE
S1RUKWWRYFL6 / Not reported
Parent award
Not reported
Awarding agency
Department of Justice
Subagency
Federal Prison System / Bureau of Prisons
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
6555 STATE HIGHWAY 161, IRVING, DALLAS, TX, 75039
Place of performance
IRVING, DALLAS, TX, 75039
Source last modified
Oct 23, 2026

Description

CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027

    US · usaspendingSource ↗
  2. Value increased

    CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027

    US · usaspending$300Source ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Oct 20, 20260Not reported$300.00Not reportedNot reportedCONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027USAspending ↗